Cite
HARVARD Citation
Gatto, M. et al. (2020). Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real‐Life Setting. Arthritis & rheumatology. 72 (8), pp. 1314-1324. [Online].